Comparison between OBSC Perfection IPO and Onyx Biotec IPO.
OBSC Perfection IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Onyx Biotec IPO is a SME Bookbuilding proposed to list at NSE SME.
OBSC Perfection IPO | Onyx Biotec IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Bookbuilding | Bookbuilding |
Listing At | NSE SME | NSE SME |
Lead Managers | Unistone Capital Pvt.Ltd. | Horizon Management Pvt.Ltd. |
Registrar | Bigshare Services Pvt.Ltd. | MAS Services Ltd. |
Market Maker | R.K.Stock Holding Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
DRHP | DRHP ![]() | DRHP ![]() |
RHP | RHP ![]() | RHP ![]() |
Anchor Investor | Anchor Investor ![]() | Anchor Investor ![]() |
IPO Allotment URL | IPO Allotment URL ![]() | IPO Allotment URL ![]() |
The total issue size of OBSC Perfection IPO is up to ₹62.69 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹27.85 Cr. The final issue price of OBSC Perfection IPO is ₹100.00 per share and of Onyx Biotec IPO is ₹61.00 per share.
OBSC Perfection IPO | Onyx Biotec IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹95.00 per share | ₹58.00 per share |
Issue Price (Upper) | ₹100.00 per share | ₹61.00 per share |
Issue Price (Final) | ₹100.00 per share | ₹61.00 per share |
Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
Discount (Employee) | ||
Market Lot Size | 1200 shares | 2000 shares |
Fresh Issue Size | 62,68,800 shares | 45,66,000 shares |
Fresh Issue Size (Amount) | up to ₹62.69 Cr | up to ₹27.85 Cr |
OFS Issue Size | 0 shares | 0 shares |
OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Issue Size Total | 62,68,800 shares | 45,66,000 shares |
Issue Size Total (Amount) | up to ₹62.69 Cr | up to ₹27.85 Cr |
OBSC Perfection IPO opens on Oct 22, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of OBSC Perfection IPO and Onyx Biotec IPO is Oct 24, 2024, and Nov 18, 2024, respectively.
OBSC Perfection IPO | Onyx Biotec IPO | |
---|---|---|
Anchor Bid Date | Oct 21, 2024 | Nov 12, 2024 |
Issue Open | Oct 22, 2024 | Nov 13, 2024 |
Issue Close | Oct 24, 2024 | Nov 18, 2024 |
Basis Of Allotment (Tentative) | Oct 25, 2024 | Nov 19, 2024 |
Initiation of Refunds (Tentative) | Oct 28, 2024 | Nov 20, 2024 |
Credit of Share (Tentative) | Oct 28, 2024 | Nov 20, 2024 |
Listing date (Tentative) | Oct 29, 2024 | Nov 22, 2024 |
Anchor Lockin End date 1 | Nov 24, 2024 | Dec 19, 2024 |
Anchor Lockin End date 2 | Jan 23, 2025 | Feb 17, 2025 |
OBSC Perfection IPO P/E ratio is 14.62, as compared to Onyx Biotec IPO P/E ratio of 26.81.
OBSC Perfection IPO | Onyx Biotec IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials | OBSC Perfection Limited Financial Information (Restated)OBSC Perfection Limited's revenue increased by 20% and profit after tax (PAT) rose by 167% between the financial year ending with March 31, 2024 and March 31, 2023.
| Onyx Biotec Limited Financial Information (Restated)Onyx Biotec Limited's revenue increased by 35.99% and profit after tax (PAT) rose by 64.35% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100 | 88.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 14.62 | 26.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹244.52 Cr. | ₹110.61 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 40.61% | 4.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 31.49% | 3.71% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 1.38 | 1.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹6.84 | ₹2.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 40.61% | 4.99% |
In the OBSC Perfection IPO Retail Individual Investors (RII) are offered 21,94,800 shares while in Onyx Biotec IPO retail investors are offered 21,94,800 shares. Qualified Institutional Buyers (QIB) are offered 12,54,000 shares in OBSC Perfection IPO and 9,12,000 shares in Onyx Biotec IPO.
OBSC Perfection IPO | Onyx Biotec IPO | |
---|---|---|
Anchor Investor Reserveration | 18,79,200 shares | 13,66,000 shares |
Market Maker Reserveration | 3,33,600 shares | 2,44,000 shares |
QIB | 12,54,000 shares | 9,12,000 shares |
NII | 9,40,800 shares | 6,88,000 shares |
RII | 21,94,800 shares | 16,00,000 shares |
Employee | ||
Others | ||
Total | 62,68,800 shares | 45,66,000 shares |
OBSC Perfection IPO subscribed 16.56x in total, whereas Onyx Biotec IPO subscribed 198.00x.
OBSC Perfection IPO | Onyx Biotec IPO | |
---|---|---|
QIB (times) | 10.20x | 32.49x |
NII (times) | 25.87x | 602.86x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 16.20x | 118.26x |
Employee (times) | ||
Other (times) | ||
Total (times) | 16.56x | 198.00x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O